22. A pharmaceutical strategy for Europe (debate)

Verbatim reports

Report on a pharmaceutical strategy for Europe [2021/2013(INI)] - Committee on the Environment, Public Health and Food Safety. Rapporteur: Dolors Montserrat (A9-0317/2021)

Dolors Montserrat introduced the report.

The following spoke: Marc Botenga (rapporteur for the opinion of the ITRE Committee).

The following spoke: Stella Kyriakides (Member of the Commission).

The following spoke: Luisa Regimenti (rapporteur for the opinion of the JURI Committee), Pernille Weiss, on behalf of the PPE Group, Alessandra Moretti, on behalf of the S&D Group, and Véronique Trillet-Lenoir, on behalf of the Renew Group.

IN THE CHAIR: Lívia JÁRÓKA
Vice-President

The following spoke: Tilly Metz, on behalf of the Verts/ALE Group, Simona Baldassarre, on behalf of the ID Group, Joanna Kopcińska, on behalf of the ECR Group, Kateřina Konečná, on behalf of The Left Group, Mislav Kolakušić, non-attached Member, Sunčana Glavak, César Luena, Susana Solís Pérez, Jutta Paulus, Mathilde Androuët, Eugen Jurzyca, Marisa Matias, Stelios Kympouropoulos, Ladislav Ilčić, João Pimenta Lopes, Tomislav Sokol, Juozas Olekas, Clare Daly and Angelika Niebler.

The following spoke: Stella Kyriakides.

The debate closed.

Vote: minutes of 23.11.2021, item 3 (amendments); minutes of 24.11.2021, item 7 (final vote).

Announcement of voting results: minutes of 23.11.2021, item 6 (amendments); minutes of 24.11.2021, item 10 (final vote).